Impact of the allergen-specific immunotherapy in pediatric patients with asthma treated at a health institution in Colombia

Jorge Andrés Puerto, Susana Uribe , Víctor Calvo, Ricardo Cardona, .

Keywords: Immunotherapy, asthma, pediatrics, mites, spirometry, rhinitis

Abstract

Introduction: Asthma is a chronic and potentially serious disease and 80% of the cases have an allergic etiology. In this sense, allergen-specific immunotherapy is an alternative that modulates the natural course of the disease.
Objective: To evaluate the impact of immunotherapy in pediatric asthma patients treated at a health institution in Colombia.
Materials and methods: We conducted an observational descriptive study with an analytical cross-sectional component. Sixty-two patients diagnosed with allergic asthma sensitized to dust mites and treated with at least 6 doses of mite immunotherapy were included. We assessed the impact of immunotherapy using the Asthma Control Test (ACT), the Global Initiative for Asthma (GINA) treatment scale, and spirometry values.
Results: The ACT score before the start reported 30% of patients with uncontrolled asthma, 28% with good control, and 4% with totally controlled asthma. Of the patients with uncontrolled asthma, 46.7% achieved good control and 23.3% total control. Regarding patients’ perception of improvement with the immunotherapy, 9.75% perceived a response of less than 50%, 45.2% one between 50% -90%, and 41.9% reported response equal to or greater than 90%. No significant changes in FEV1 values were found in spirometry.
Conclusions: Significant changes in the ACT scores and the perception of disease improvement were observed in the population evaluated with specific mite immunotherapy, i.e., it had a positive impact on the natural course of the disease.

Downloads

Download data is not yet available.
  • Jorge Andrés Puerto Grupo de Alergología Clínica y Experimental, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia
  • Susana Uribe Grupo de Alergología Clínica y Experimental, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia https://orcid.org/0000-0002-9535-763X
  • Víctor Calvo Grupo de Alergología Clínica y Experimental, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia https://orcid.org/0000-0002-9107-4093
  • Ricardo Cardona Grupo de Alergología Clínica y Experimental, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia https://orcid.org/0000-0002-7428-2413

References

Russell RJ, Brightling C. Pathogenesis of asthma: Implications for precision medicine. Clin Sci. 2017;131:1723-35. https://doi.org/10.1042/CS20160253

Dennis R, Caraballo L, García E, Caballero A, Aristizábal G, Córdoba H, et al. Asthma and other allergic conditions in Colombia: A study in 6 cities. Ann Allergy Asthma Immunol. 2004;93:568-74. https://doi.org/10.1016/S1081-1206(10)61265-3

Dennis RJ, Caraballo L, García E, Rojas MX, Rondón MA, Pérez A, et al. Prevalence of asthma and other allergic conditions in Colombia 2009-2010: A cross-sectional study. BMC Pulm Med. 2012;12:17. https://doi.org/10.1186/1471-2466-12-17

Global Initiative for Asthma. Pocket guide for asthma management: For adults and children over 5 years. GINA; 2019. Fecha de consulta: 26 de noviembre de 2019. Disponible en: https://ginasthma.org/wp-content/uploads/2019/04/GINA-2019-main-Pocket-Guide-wms.pdf

Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, et al. Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010;126:926-38. https://doi.org/10.1016/j.jaci.2010.07.019

Tran TN, Zeiger RS, Peters SP, Colice G, Newbold P, Goldman M, et al. Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma. Ann Allergy Asthma Immunol. 2016;116:37-42. https://doi.org/10.1016/j.anai.2015.10.027

Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127:355-60. https://doi.org/10.1016/j.jaci.2010.11.037

Posa D, Perna S, Resch Y, Lupinek C, Panetta V, Hofmaier S, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017;139: 541-9.e8. https://doi.org/10.1016/j.jaci.2016.08.014

Durham SR. Allergen immunotherapy: 100 years on. Clin Exp Allergy. 2011;41:1171. https://doi.org/10.1111/j.1365-2222.2009.03843.x

Yepes-Núñez JJ, Gómez C, Espinoza Y, Cardona R. Impacto de la inmunoterapia subcutánea con Dermatophagoides farinae y Dermatophagoides pteronyssinus sobre la calidad de vida de pacientes con rinitis y asma alérgica. Biomédica. 2014;34:282-90. https://doi.org/10.7705/biomedica.v34i2.1744

Gaviria R, Ocampo J, Londoño J, Calvo V, Cardona R, Sánchez J. Sensibilización IgE y las condiciones sociodemográficas como determinantes en la gravedad del asma. Revista Alergia México. 2017;64:439. https://doi.org/10.29262/ram.v64i4.291

Rothman KJ, Gallacher JE, Hatch EE. Why representativeness should be avoided. Int J Epidemiol. 2013;42:1012-4. https://doi.org/10.1093/ije/dys223

Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117:549-56. https://doi.org/10.1016/j.jaci.2006.01.011

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl.86):8-160. https://doi.org/10.1111/j.1398-9995.2007.01620.x

Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018;73:765-98. https://doi.org/10.1111/all.13317

Gandhi VD, Davidson C, Asaduzzaman M, Nahirney D, Vliagoftis H. House dust mite interactions with airway epithelium: Role in allergic airway inflammation. Curr Allergy Asthma Rep. 2013;13:262-70. https://doi.org/10.1007/s11882-013-0349-9

Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2010. Cochrane Database Syst Rev. 2010;CD001186. https://doi.org/10.1002/14651858.cd001186.pub2

Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 2017;72:1825-48. https://doi.org/10.1111/all.13208

Acevedo N, Zakzuk J, Caraballo L. House dust mite allergy under changing environments. Allergy Asthma Immunol Res. 2019;11:450-69. https://doi.org/10.4168/aair.2019.11.4.450

Sánchez-Caraballo J, Diez-Zuluaga S, Cardona-Villa R. Sensitization to aeroallergens in allergic patients from Medellín, Colombia. Rev Alerg Mex. 2012;59:139-47.

Fernández-Caldas E, Puerta L, Mercado D, Lockey RF, Caraballo LR. Mite fauna, Der pI, Der f I and Blomia tropicalis allergen levels in a tropical environment. Clin Exp Allergy. 1993;23:292-7. https://doi.org/10.1111/j.1365-2222.1993.tb00325.x

How to Cite
1.
Puerto JA, Uribe S, Calvo V, Cardona R. Impact of the allergen-specific immunotherapy in pediatric patients with asthma treated at a health institution in Colombia. biomedica [Internet]. 2021 Sep. 22 [cited 2024 May 17];41(3):481-92. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/5673

Some similar items:

Published
2021-09-22
Section
Original articles

Altmetric

Funding data

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
QR Code